Abstract
Background The opioid epidemic remains an emergent health issue in the United States, as opioid-related deaths continue to rise in the second year of COVID-19. The introduction of synthetic opioids into the illicit supply began causing deaths in 2015, however, data describing the illicit opioid supply is scarce.
Methods We used a newly available national dataset of drug seizure reports, aggregated from law enforcement agencies across the United States, to describe changes in fentanyl, heroin, and other opioid presence in the national illicit supply from 2011-2017, by state and geographic region. We assessed the relationship between drug seizures and opioid-related deaths at the state level using linear regression.
Results National and state increases in opioid seizure rates from 2011-2017 were entirely due to increased fentanyl and heroin seizures, as other opioid seizure rates remained constant. Most increases in seizures occurred in the Northeast, Midwest, and Appalachia, where fentanyl seizures and heroin seizures were highest and increased most sharply along with opioid deaths. The composition of drugs seized was similar within geographic regions, but did vary across regions. State opioid seizures of all types were strongly associated with state opioid deaths. The strongest relationship was between fentanyl seizures and fentanyl deaths.
Conclusions The association between opioid seizures and deaths means seizure data has potential as an early-warning system to predict overdose, although national level data requires quality improvement. Regional variation in seizure rates supports existing evidence that illicit fentanyl and heroin supplies differ between regions, producing distinct regional risk environments, causing varying mortality rates.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced are available online at https://github.com/heathermcb/national_seizure.
